Ines Pires daSilva

17PUBLICATIONS
98CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 08, 2026
Impact of adjuvant therapy on melanoma-specific survival in elderly patients with high-risk resected melanoma: a multicenter international retrospective study.

|Oct 01, 2026
Five-year survival with neoadjuvant therapy in melanoma: updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).

|May 27, 2026
Immunotherapy for early-stage cutaneous squamous cell carcinoma.

|May 04, 2026
Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases.

|Mar 12, 2026
Molecular Profiling and Matched Targeted Therapy for Patients With Advanced Melanoma: Results From Part 1 of the MatchMEL Study.

Andrea Boutros, Matteo S Carlino, Raja Chaganti

|Nov 28, 2025
International real-world study of combination immunotherapy sequences in metastatic melanoma.

Mora Guardamagna, Sarah E Lochrin, James William Smithy

Pageof 3

Frequent Collaborators

12 joint publications

Serigne N Lo

9 joint publications

Alexander Maxwell Menzies

8 joint publications

Richard A Scolyer

7 joint publications

Georgina V Long